Somatostatin analogues inhibit in vitro cell proliferation via specific membrane receptors (SSTRs). Recent studies on transfected cell lines have shown a ligand-induced formation of receptor dimers. The aim of this study is 1) to evaluate the role of specific ligands in modulating receptor interactions in the androgen-dependent prostate cancer cell line, LNCaP, and in the non-small cell lung cancer line, Calu-6, by co-immunoprecipitation and immunoblot; and 2) to correlate the antiproliferative effect of these compounds with their ability in modulating receptor interactions. In LNCaP, we have demonstrated the constitutive presence of sstr 1 /sstr 2 , sstr 2 /sstr 5 , sstr 5 /dopamine (DA) type 2 receptor (D 2 R), and sstr 2 /D 2 R dimers. BIM-23704 (sstr 1 -and sstr 2 -preferential compound) increased the co-immunoprecipitation of sstr 1 /sstr 2 and significantly inhibited proliferation (K30 . 98%). BIM-23244 (sstr 2 -sstr 5 selective agonist) significantly increased the co-immunoprecipitation of sstr 2 /sstr 5 , and induced a K41 . 36% inhibition of proliferation. BIM-23A760, a new somatostatin/DA chimeric agonist with a high affinity for sstr 2 and D 2 R and a moderate affinity for sstr 5 , significantly increased the sstr 5 /D 2 R and sstr 2 /D 2 R complexes and was the most powerful in inhibiting proliferation (K42 . 30%). The chimeric compound was also the most efficient in modulating receptor interaction in Calu-6, increasing the co-immunoprecipitation of D 2 R/sstr 5 and inhibiting cell proliferation (K30 . 54%). However, behind BIM-23A760, BIM-53097 (D 2 R-preferential compound) also significantly inhibited Calu-6 proliferation (K17 . 71%), suggesting a key role for D 2 R in receptor cross talk and in controlling cell growth. Indeed, activation of monomeric receptors did not affect receptor co-immunoprecipitation, whereas cell proliferation was significantly inhibited when the receptors were synergistically activated. In conclusion, our data show a dynamic ligand-induced somatostatin and DA receptor interaction, which may be crucial for the antiproliferative effects of the new analogues.
Introduction
Somatostatin (or somatotropin release-inhibiting factor, SRIF) acts through five specific G-protein-coupled membrane receptors (SSTRs), code named sstr [1] [2] [3] [4] [5] , expressed in SRIFtarget cells (Patel 1999 , Møller et al. 2003 . SRIF mainly exerts an inhibitory effect on cell functions, such as secretion and proliferation (Lamberts et al. 2002) . The inhibitory activity of SRIF is replicated by the SRIF analogues octreotide and lanreotide, already used in the clinical practice to control hormonal hypersecretion by the pathological tissues highly expressing sstr 2 , such as GH-producing pituitary adenomas or certain neuroendocrine tumors (Weckbecker et al. 2003) . The stimulation of SSTRs by SRIF analogues may also produce an antiproliferative effect in vitro, due to either cell cycle arrest or induction of apoptosis (Danila et al. 2001 , Ferone et al. 2002 , Ferrante et al. 2006 , Florio 2008 .
In the past years, the knowledge about SSTRs physiopathology has been extended by the discovery that SSTRs can interact on cell membrane forming receptor dimers (Rocheville et al. 2000a) . A series of studies, carried out on transfected cell lines, have shown that dimers can consist of two identical SSTR subtypes (homodimers) or two different subtypes (heterodimers), with a range of possible combinations depending on the specific subtype and, probably, on the specific SSTR-expressing cell population. SSTR dimerization can be a ligand-dependent phenomenon, since natural SRIF and subtype-specific SRIF agonists have different effects on dimerization, leading to formation or, on the contrary, dissociation of SSTR dimers (Rocheville et al. 2000a , Pfeiffer et al. 2001 , Patel et al. 2002 , Grant et al. 2004a ,b, 2008 . SSTR homo-and heterodimerization also involve cellular events beyond the membrane, since it modifies SSTR internalization and trafficking (Baragli et al. 2007) , as well as signal transduction (Kidd et al. 2008) . SSTRs can also heterodimerize with other G-protein-coupled receptors, such as the m-opioid receptor (Pfeiffer et al. 2002) and dopamine (DA) type 2 receptor (D 2 R; Rocheville et al. 2000b , Baragli et al. 2007 .
The heterodimerization of these G-protein-coupled receptors and the related cellular events open a new possible scenario in the field of treatments targeting SSTR-expressing tumors (Papotti et al. 2002) . In fact, new SRIF analogues, which bind more than one SSTR subtype (Weckbecker et al. 2003) and chimeric compounds binding SSTRs and D 2 R, have been developed and are now available for phase 2 studies (Ferone et al. 2007) . Indeed, SSTRs and D 2 R are frequently co-expressed in those diseases for which therapies with SRIF analogues have already been approved (O'Toole et al. 2006 , Ferone et al. 2008 , Srirajaskanthan et al. 2009 ). However, only few studies have been performed to evaluate the final consequences of G-protein-coupled receptors dimerization on cell functions so far (Ferone et al. 2005 , Grant et al. 2008 , and the clinical relevance of SSTR and D 2 R heterodimerization must be proved.
In this study, we analyzed the effects of different SRIF analogues and of one SRIF/DA chimeric compound on SSTRs and D 2 R interaction on cell membrane and cell proliferation in a cell line constitutively expressing four out of five SSTRs, the androgen-dependent prostate cancer cell line LNCaP (Ruscica et al. 2010) , and in a cell line constitutively expressing three out of four SSTRs and the D 2 R, the non-small cell lung cancer (NSCLC) line Calu-6 (Ferone et al. 2005) .
Materials and Methods

Cell cultures
Human androgen-dependent prostate cancer (LNCaP) and NSCLC (Calu-6) lines, both from American Type Culture Collection (Rockville, MD, USA), were grown at 37 8C in a humidified CO 2 incubator in monolayer. The culture media were RPMI 1640 supplemented with 10 mg/l phenol red, and 10% FBS for LNCaP and MEM supplemented with 10% FBS, 1% non-essential amino acids, 20 mg/dl gentamycin, 200 mM glutamine, and 1 mM sodium pyruvate for Calu-6 cells. Subconfluent cells were collected with 0 . 05% trypsin/0 . 02% EDTA (Biochrom, Berlin, Germany) and were seeded into 150 cm 2 flasks or in 96-well plates depending on the experiments.
Products
The SRIF analogues lanreotide (BIM-23014), the bi-specific sstr 2 /sstr 5 -preferential compound BIM-23244, the sstr 2 -preferential compound BIM-23120, the sstr 5 -preferential compound BIM-23206, the sstr 1 -preferential compound BIM-23926, the bi-specific sstr 1 /sstr 2 -preferential compound BIM-23704 with a relative lower affinity for sstr 3 , the sstr 2 /sstr 5 /D 2 R chimeric compound BIM-23A760, and the D 2 R-preferential compound BIM-53097 were used in this study and their respective affinities (K i ) are listed in Table 1 . All experimental compounds were kindly provided by IPSEN/Biomeasure (Milford, MA, USA).
RNA extraction and reverse transcription-PCR analysis
For RNA studies, cells were washed with cold PBS, collected, snap-frozen in liquid nitrogen, and stored at K80 8C until RNA extraction. Non-functional pituitary adenoma, obtained from surgery, was taken as positive controls. Total cellular RNA was extracted with the phenol-chloroform method using the Tri Reagent solution (Sigma-Aldrich). Reverse transcription (RT)-PCR analysis for the expression of gene coding for D 2 R was performed on total RNA samples. The RT reaction was carried out in a 20 ml volume, using a commercially available kit (Superscript VILO cDNA Synthesis kit; Invitrogen). The primers used to detect the expression of human D 2 R mRNA were as follows: forward (5 0 -gCg gAC AgA CCC CAC TAC AA-3 0 ) and reverse (5 0 -AAg ggC ACg Tag AAg gAg AC-3 0 ). 
Membrane protein extraction
For membrane protein extraction, 5!10 6 cells from both the cell lines were seeded into 150 cm 2 flasks in the appropriate culture media. After 24 h of starvation in serum-free media, the culture medium was replaced by adding the experimental medium containing somatostatin analogues (concentration 10 K9 M). After a 24 h incubation, LNCaP and Calu-6 were solubilized in lysis buffer (20 mM HEPES, 5 mM EDTA, 3 mM EGTA, 150 mM NaCl, 1 mM phenylmethylsulphonyl fluoride, 10 mg/ml soybean trypsin inhibitor, 10 mg/ml leupeptin, and 50 mg/ml bacitracin) and subsequently centrifuged at 20 000 g. Membrane pellet was resuspended with lysis buffer combined with 4 mg/ml dodecyl-D-maltoside, incubated for 1 h on ice, and centrifuged at 20 000 g at 4 8C. Glycosylated proteins were immobilized by recycling the solubilized membrane proteins of the supernatant through a 0 . 5 ml wheat germ agglutinin (Vector Laboratories, Burlingame, CA, USA) column overnight at 4 8C. The column was eluted with lysis buffer containing 3 mM N,N 0 ,N-triacetylchitotriose (Sigma-Aldrich). The protein content of the eluted protein was assessed by Bio-Rad Protein assay (Bio-Rad).
Immunoblot analysis
For D 2 R, sstr 1 , and sstr 5 protein detection and for dimerization studies, 100 mg of LNCaP and Calu-6 membrane receptors and the supernatants obtained after immunoprecipitation were fractioned on 12 . 5% SDS-PAGE and were electrophoretically transferred to Hybond-C extra nitrocellulose membrane (GE Healthcare, Chalfont, St Giles, UK). Non-specific binding sites were blocked by treating the membranes with Tris-buffered saline-Tween (TBS-T: 0 . 02 M Tris, 0 . 137 M NaCl, and 0 . 5% Tween 20; pH 7 . 6 with 1 M HCl) containing 5% non-fat dried milk for 1 h at 22 8C on a rotating shaker. After three washes with TBS-T, membranes were incubated for 16 h at 4 8C with a 1:500 dilution of mouse anti-human D 2 R monoclonal antibody, rabbit anti-human sstr 1 polyclonal antibody, rabbit anti-human sstr 2 polyclonal antibody, rabbit anti-human sstr 5 polyclonal antibody (all antibodies from Santa Cruz Biotechnology, Santa Cruz, CA, USA), and 1:500 dilution of a mouse anti-human sstr 2 polyclonal antibody (Novus Biologicals, Littleton, CO, USA) according to the experiment, in TBS-T containing 3% BSA. Membranes were washed three times with TBS-T and then incubated for 1 h at 22 8C with 1:2000 dilution of HRP-linked anti-rabbit/mouse IgG (according to the primary antibody), washed as before, and immersed for 0 . 5-1 min in the chemiluminescence-detection solution. Subsequently, membranes were exposed for 0 . 5 min to generate immunoblots. As internal control, membranes used for sstr 1 and sstr 5 expressions were stripped and reprobed with an antitubulin monoclonal antibody (1:2000; 1A2 clone MoAb, Sigma).
Quantification of the digitized bands was performed in three different experiments (nZ3) by UN-SCAN-IT software (Silk Scientific, Orem, UT, USA) according to the software instructions. In brief, for each band, the net optical density level was automatically determined by subtracting the background optical level from the total raw optical density level and the mean was calculated. Data were expressed as arbitrary density units and were normalized according to the total amount of each receptor subtype after a 24 h treatment.
Immunoprecipitation
LNCaP and Calu-6 membrane receptors (300 mg) were immunoprecipitated with a mouse anti-human sstr 2 (Novus Biologicals), a rabbit anti-human sstr 5 polyclonal antibody, and a mouse anti-human D 2 R monoclonal antibody (Santa Cruz Biotechnology) in the presence of 20 ml protein-A agarose (Sigma-Aldrich) overnight at 4 8C on a rotating shaker. After washing with lysis buffer, the protein-A-conjugated immunocomplex was boiled for 5 min with sample buffer (6% SDS, 0 . 24 M Tris-HCl 0 . 5 M, pH 6 . 8, 30% glycerol, 0 . 3 mg/ml BPB, 50 mM dithiothreitol) and centrifuged at 1000 g for 30 s to denature and separate the immunocomplex from protein-A agarose. Supernatants were subjected to immunoblot analysis as described in the previous section.
Cell proliferation studies
To estimate proliferating cells in the S phase of the cell cycle, 15!10 3 cells from both the cell lines were seeded into 96-well plates in a final volume of 200 ml/well and incubated at 37 8C in a humidified 5% CO 2 atmosphere for 48 h. Then, the culture medium was replaced by adding 180 ml of the experimental medium (RPMI 1640/2% FCS for LNCaP cells and DMEM serum-free 0 . 1% BSA for Calu-6) containing SRIF analogues and the chimeric compound (10 K9 M). After 48 h (LNCaP) and 24 h (Calu-6), proliferation was measured by cell counting and by measuring thymidine incorporation after the addition of 1 mCi [methyl-3 H]-thymidine ( 3 H-Thy; Amersham) during the last 6 h of incubation.
3 H-Thy incorporation was determined after collecting cells on glass fibers filter and counting on a scintillation b-counter. Results were obtained by determining the mean value of at least four experiments in eight replicates and expressed as D% of the control.
Statistical analysis
Data were expressed as meanGS.D. for cell proliferation and meanGS.E.M. for co-immunoprecipitation studies. All data were analyzed by ANOVA to determine the overall differences between the groups, followed by t-test (P!0 . 05 was considered significant).
The correlation study was performed by using a linear regression analysis and by calculating the determination coefficient (R 2 ). To minimize variation among different experiments, the results were expressed as relative variation from untreated control value (D% of control value).
Results
LNCaP cell line D 2 R gene and protein expression We have already reported the SSTR and D 2 R profile in Calu-6, as well as the SSTR content in LNCaP (Ferone et al. 2005 , Ruscica et al. 2010 , hence, before any test we sought to determine the gene and protein expression of D 2 R in LNCaP cells, by means of RT-PCR and western blot analysis. By using specific oligoprimers, we detected a product of 523 bp corresponding to the D 2 R mRNA. Ribosomal 18S was used as internal control for RT-PCR. Moreover, the analysis by immunoblotting of LNCaP cell extracts, using a specific human D 2 R antibody, showed an immunoreactive band of apparent molecular mass of 40 . . 5 kDa, depending on protein glycosylation (Fig. 1) .
Receptor interaction A weak signal of constitutive receptor dimers was demonstrated on the membranes of LNCaP cell line. In particular, we detected the presence of sstr 1 /sstr 2 , sstr 2 /sstr 5 , sstr 5 /D 2 R, and sstr 2 /D 2 R complexes ( Fig. 2A-D) . Treatment with BIM-23704, an sstr 1 /sstr 2 -preferential compound (with a relative lower affinity for sstr 3 as well), increased the amount of sstr 1 co-immunoprecipitated with sstr 2 compared with untreated cells (P!0 . 05; Fig. 2A ).
This compound did not affect the amount of sstr 2 /sstr 5 complex (Fig. 2B) , however, surprisingly, it was also able to increase either the amount of D 2 R co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 2C ) or the amount of D 2 R co-immunoprecipitated with sstr 2 (P!0 . 01; Fig. 2D ). Treatment with BIM-23244, a compound with a high affinity for sstr 2 and sstr 5 , significantly increased the amount of sstr 2 co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 2B ) and the amount of D 2 R co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 2C ), without affecting the amount of sstr 1 /sstr 2 and the D 2 R/sstr 2 complexes ( Fig. 2A and D) . As expected, treatment with BIM-23014, a compound with a high affinity for sstr 2 and a relative low affinity for sstr 5 , increased the amount of sstr 2 co-immunoprecipitated with sstr 5 (P!0 . 05; Fig. 2B ), but it was also able to increase sstr 1 /sstr 2 (P!0 . 01; Fig. 2A ) and D 2 R/sstr 5 complexes (P!0 . 01; Fig. 2C ). Conversely, this compound did not affect the D 2 R/sstr 2 complex (Fig. 2D) . BIM-23A760, the chimeric sstr 2 /D 2 R compound (with a relative high affinity for sstr 5 ), was one of the most powerful molecules in increasing the amount of D 2 R co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 2C ) and the amount of D 2 R co-immunoprecipitated with sstr 2 (P!0 . 01; Fig. 2D ), apparently without influencing the sstr 1 /sstr 2 and sstr 2 /sstr 5 receptor complexes ( Fig. 2A and B) . BIM-53097, the D 2 R analogue, displayed a profile similar to that of BIM-23A760 ( Fig. 2A-D) .
Twenty-four hour treatment with all tested substances did not induce any modification of sstr 1 expression (Fig. 2E) . Similarly, in line with the results obtained by Froidevaux et al. (1999) , either the amount of sstr 2 or the amount of D 2 R on cell membrane did not show any difference between untreated and treated cells (data not shown).
Cell proliferation The compounds tested in this study produced different antiproliferative effects, as displayed in Fig. 3 . According to the above described ability in inducing SSTR/D 2 R interaction, the chimeric compound BIM-23A760 showed the highest antiproliferative effect constitutive receptor interactions were demonstrated on the membranes of Calu-6 cell line as well. In particular, we detected a significant amount of sstr 2 co-immunoprecipitated with sstr 5 and sstr 5 with D 2 R on the membranes of these cells ( Fig. 4A and B) . Treatment with BIM-23014 (a high affinity for sstr 2 and a low affinity for sstr 5 ) strongly increased the amount of sstr 2 co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 4A ) without affecting sstr 5 /D 2 R and sstr 2 /D 2 R interactions ( Fig. 4B and C) . The bi-specific compound with a high affinity for both sstr 2 and sstr 5 , BIM-23244, increased the amount of sstr 2 co-immunoprecipitated with sstr 5 (P!0 . 01; Fig. 4A ), as well as sstr 2 co-immunoprecipitated with D 2 R (P!0 . 05; Fig. 4C ). Conversely, BIM-23A760, the chimeric compound, with a high affinity for sstr 2 and D 2 R, and a moderate affinity for sstr 5 , significantly increased the amount of both sstr 2 co-immunoprecipitated with sstr 5 and sstr 5 co-immunoprecipitated with D 2 R (P!0 . 01; Fig. 4A and B) without affecting sstr 2 co-immunoprecipitated with D 2 R (Fig. 2C) . BIM-53097, the D 2 R-preferential compound, significantly increased the amount of sstr 5 co-immunoprecipitated with D 2 R (P!0 . 01; Fig. 4B ), as well as sstr 2 co-immunoprecipitated with D 2 R (P!0 . 05; Fig. 4C ). Twenty-four hours treatment with all the tested substances did not induce any modification of sstr 5 expression (Fig. 4D) , as well as sstr 2 and D 2 R (data not shown), as already described (Froidevaux et al. 1999) .
Cell proliferation The chimeric compound BIM-23A760
resulted significantly more effective in inhibiting cell proliferation compared with all the other compounds, tested (Fig. 5) . Confirming an important involvement of D 2 R in the regulation of cell functions, BIM-53097 showed also a significant inhibition of cell proliferation (K17 . 34G1 . 95% versus control).
Correlations We investigated the correlations between receptor interaction and cell proliferation of the treated cells by comparing the ligand-induced receptor co-immunoprecipitation with the inhibition of cell proliferation (both evaluated as D% of control). The amount of sstr 2 co-immunoprecipitated with sstr 5 was not correlated (R 2 0 . 0003; PZ0 . 5) with the inhibition of cell proliferation in both cell lines. Conversely, the amount of sstr 5 co-immunoprecipitated with D 2 R was directly and significantly correlated (R 2 0 . 87; PZ0 . 001) with the inhibition of cell proliferation in both cell lines (Fig. 6) .
Discussion
Several studies focusing on the effect of SRIF and DA analogues on the control of cell secretion and proliferation have demonstrated a broad profile of action, both in vivo and in vitro, in different tissues besides the neuroendocrine ones (Lamberts et al. 2002 , Schally & Nagy 2003 . There are also increasing evidences that SRIF and DA receptors can interact on cell membrane forming homo-or heterodimers with an enhanced functional activity (Ferone et al. 2009 ). Moreover, almost all studies carried out on cell lines showed receptor dimerization in transfected models highly expressing at least two receptor subtypes (Rocheville et al. 2000a , Pfeiffer et al. 2001 , Ren et al. 2003 . In this study, we have used two tumor cell lines constitutively expressing four (LNCaP) and three (Calu-6) out of the five SRIF receptors (Ferone et al. 2005 , Ruscica et al. 2010 ) and the D 2 R. These non-neuroendocrine cell lines, because of their constitutive and relatively low receptor expression, represent a useful model to investigate the physiological mechanisms involved in protein membrane interaction, such as receptor dimerization. Since recently new SRIF analogues with a specific affinity for given receptor subtypes, and SRIF/DA chimeric compounds have been CONTR, control (untreated cells). *P!0 . 05; **P!0 . 01. M ARVIGO, F GATTO and others . Somatostatin/dopamine receptor interactions developed (Ferone et al. 2005 , Saveanu & Jaquet 2009 , in this study we have investigated the effect of these compounds on receptor interaction, and correlated the occurrence of co-immunoprecipitated receptors with the impact on cell proliferation. Since we already demonstrated a dose-response effect of these compounds in the inhibition of cell proliferation (Ferone et al. 2005) , in this study, we have performed all experiments using the concentration of compounds that demonstrated about a 50% inhibitory effect (10 K9 M). According to the baseline expression of SSTR subtypes in the two cell lines (Ferone et al. 2005 , Ruscica et al. 2010 and to the ineffectiveness of a 24 h treatment on receptor expression, we tested specific SRIF analogues in order to study the different combinations of (potential) receptor interaction. Indeed, in LNCaP cell line, we tested the bi-specific SRIF compounds targeting sstr 1 , sstr 2 , and sstr 5 , and in Calu-6 cell line, the bi-specific SRIF compounds targeting sstr 2 and sstr 5 .
Since we have demonstrated the expression of D 2 R in both the cell lines, we also tested the sstr 2 /sstr 5 /D 2 R chimeric compound and the D 2 R analogue in order to evaluate the involvement of D 2 R in membrane receptor interaction.
The results of western blot and co-immunoprecipitation experiments clearly demonstrated that all SSTRs investigated were able to co-immunoprecipitate with other SSTRs and/or with D 2 R. Moreover, the results of this study confirmed the ability of SSTRs and D 2 R to interact on plasma membrane, even in the absence of ligands. On the basis of a strong specificity of the receptors subtype antibodies we used, we considered the co-immunoprecipitated receptor as an expression of the presence of constitutive heterodimer. Moreover, besides observing receptor co-immunoprecipitation in basal conditions, we found that treatment with SRIF analogues and with an SRIF/DA chimeric compound can differently modulate the amount of the potential dimers on plasma membranes.
As far as LNCaP cell line is concerned, all compounds targeting sstr 2 showed the ability to increase the interaction between almost all the receptors studied, in particular the interaction between SSTR and D 2 R. As a matter of fact, we observed that lanreotide was able to increase the amount of sstr 5 co-immunoprecipitated with D 2 R, as well as BIM-23704, despite its prevalent affinity for sstr 1 /sstr 2 /sstr 3 . As expected, the chimeric compound BIM-23A760 drastically increased the amount of SSTR co-immunoprecipitated with D 2 R, resulting in one of the most effective antiproliferative agents among all tested molecules. This last finding suggests a crucial role of D 2 R in the mechanism involved in the control of tumor growth in these cells, as confirmed by the significant antiproliferative effect and by the increase in the amount of sstr 2 co-immunoprecipitated with D 2 R exerted by the monospecific D 2 R compound, BIM-53097. Since the sstr 2 monospecific compound failed to display a significant antiproliferative effect, and sstr 1 and sstr 3 , but not sstr 2 , are the receptor subtypes mostly involved in the pathophysiology of prostate cancer, we deduced that sstr 2 might mainly function as a 'scaffold' for other receptors in the formation of heterodimers.
As far as Calu-6 cell line is concerned, we observed that sstr 2 and sstr 5 receptors exert a role in the inhibition of cell growth only when activated synergistically. This finding is supported by the effect of the sstr 2 /sstr 5 bi-specific compound, BIM-23244, either in the inhibition of cell growth or in the increase in sstr 2 co-immunoprecipitated with sstr 5 . Moreover, Calu-6 cell line displayed a greater sensibility to the chimeric compounds compared with that observed in LNCaP cells, showing an increase in the amount of sstr 5 co-immunoprecipitated with D 2 R. Moreover, even though the chimeric compound BIM-23A760 was basically ineffective in modulating sstr 2 /D 2 R co-immunoprecipitation, it displayed a significant antiproliferative effect. However, considering the affinity of BIM-23A760 for sstr 5 as well, this apparent discrepancy can be explained by the predominant involvement of this latter receptor subtype and of D 2 R, instead of sstr 2 , in this cell line. Indeed, the inhibition Figure 6 Correlation between sstr 2 /sstr 5 and D 2 R/sstr 5 interaction and cell proliferation in LNCaP (triangles) and Calu-6 (squares). On the x-axis the arbitrary density units (AU ratio) of calculated density (D%) and on the y-axis the D% of thymidine incorporation versus control are reported. The results were obtained by using a linear regression analysis calculating the determination coefficient (R of cell proliferation exerted by the sstr 2 -preferential compound, BIM-23120, was negligible. This finding is in agreement with the increase in sstr 5 co-immunoprecipitated with D 2 R induced by BIM-53097 (D 2 R-preferential compound), supporting again the important role of D 2 R in the induction of SSTR/D 2 R interaction, probably correlated to the inhibition of cell proliferation as well. These data highlight the concept of SSTRs as receptors with different functions depending on the different cells in which they are expressed, and not only from the different receptor subtype (Ferone et al. 2001 , Zatelli et al. 2001 .
In this study, we have found that the amount of SSTRs co-immunoprecipitated with D 2 R correspond to an enhanced antiproliferative activity. Nevertheless, it remains to be established whether only one receptor of the dimer accounts for the antiproliferative activity, or both receptors (dimer) modulate cell proliferation. Furthermore, we have found that the influence of different dimers on cell proliferation varies in the two different cell types. Dimers with a direct correlation with the antiproliferative effect probably act on the complex cellular system dedicated to the control of cell cycle and apoptosis (Kidd et al. 2008) . The evidence that the compounds able to induce receptor dimerization show a strong antiproliferative effect may be partially explained by the cross talk either on the cell membranes, or even at the postmembrane level, of these G-protein-coupled receptor families (Ferone et al. 2009 ). Indeed, some authors have demonstrated a reduction in receptor internalization rate, due to the ability of one receptor, implicated in the heterodimer, to retain the second receptor on the cell membrane. In this latter phenomenon, an interference with the b-arrestin system is probably involved (Grant et al. 2008) . Another possible explanation of the enhanced antiproliferative action of heterodimers (especially SSR/DR dimers) may be the increased D 2 R activity observed in the cell lines transfected with sstr 2 and D 2 R after the treatment with SRIF (Baragli et al. 2007) . Studies focused on signal transmission at the postmembrane level showed that SRIF/DA receptor activation (largely sstr 2 /D 2 R) may result in the phosphorylation of c-Jun N-terminal kinase(B) and inhibition of transcription of the cyclin Ki-67, resulting in growth arrest (Kidd et al. 2008) .
On the other hand, the presence of enhanced dimers without a direct correlation with cell proliferation sheds light into the complexity of the 'dimer system' that shows a peculiar behavior (far from being completely understood) both at the membrane and postmembrane levels.
In conclusion, the results of this study confirm that the activity of SSTRs and DA receptors could be driven by the specific cell types in which they are expressed, and demonstrate that the dimers behave similarly. Therefore, not only the receptor profiles but also the cell types, as well as the dimerization, are responsible for the final effect of a given ligand. Moreover, in the two cell systems evaluated in this study the only dimer positively correlated with an enhanced antiproliferative effect is the sstr 5 /D 2 R one. This finding opens new perspectives for the use of the new chimeric compounds, already used in phase 2 studies in neuroendocrine tumors. However, further studies are warranted to characterize the postreceptor mechanisms involved in the enhanced potency following receptor dimer activation.
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